Bewertungen in allen Sprachen anzeigen.
D'OXYVA offers a clinically validated, non-invasive technology designed to address health issues such as spider veins, chronic wounds, and reduced athletic endurance. The device delivers results in 4-8 weeks, utilizing Nobel Prize-winning scientific advances. Backed by over two dozen successful studies, it is trusted for its proven effectiveness. Research supporting D'OXYVA is conducted by top medical scientists from renowned institutions, including UCLA, MIT, and Harvard. This innovative solution provides a reliable way to enhance health and improve quality of life.
Key Details:
- Location: The company is headquartered in Pasadena, United States.
- Founders: Norbert Kiss is the CEO of D'OXYVA.
- Foundation Date: The company was established in the year 2011.